Skip to the answer

Asparaginase Erwinia Chrysanthemi Injection Uses, Dosage, Side Effects and Interactions

Brand names
Erwinaze

Erwinaze is a brand name for asparaginase erwinia chrysanthemi injection. It is not in the FDA’s directory today.

Rylaze

Rylaze is a brand of asparaginase erwinia chrysanthemi injection that comes as an injection.

Asparaginase erwinia chrysanthemi (Rylaze) is an injected enzyme medicine used with other chemotherapy to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) in people who became allergic to E. coli-derived asparaginase.

Dr. Brian Staiger, PharmD, BCPS
Last reviewed Jul 10, 2026 Content updated Nov 7, 2026 Where our facts come from

Quick links

Ask Anything About Asparaginase Erwinia Chrysanthemi InjectionType a question in your own words. Answered from its FDA label in seconds.

Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.

Asparaginase Erwinia Chrysanthemi Injection in Short

The Pharmacist’s Take

Dr. Brian Staiger, PharmD, BCPS
Clinical pharmacist Written

Rylaze is an injected enzyme that clears asparagine, an amino acid some leukemia cells cannot make themselves, from the blood. It is the backup asparaginase in chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma once someone becomes allergic to the E. coli-derived kind, and it has been on the market since about 2021 with no generic version. It is a demanding medicine, and people often notice nausea, tiredness and achy muscles and joints, while liver blood tests commonly drift out of range. Watch most closely for an allergic reaction, which is fairly common, and for severe stomach pain or vomiting, which can mean pancreatitis (an inflamed pancreas).

Key Takeaways From the HelloPharmacist Team

  • Plan on clinic visits for a shot into a muscle, every 48 hours or on a Monday, Wednesday and Friday schedule.
  • Expect medicines 30 to 60 minutes before each shot to blunt allergic reactions, and get help immediately for hives, swelling or trouble breathing.
  • Count on regular liver and blood sugar tests, and call about yellowing skin or eyes, a sudden severe headache or unusual bleeding.
  • Call your care team for any fever or sign of infection, since this treatment can leave white blood cell counts low.

How we write and review this content: our editorial policy

Asparaginase Erwinia Chrysanthemi Injection by the Numbers

Strengths
1
in one form
Makers and packagers
1
Earliest FDA record
2021
Rank by Medicaid prescriptions
#1,296 of 1,682 drugs
More prescriptions than 22% of the 1,682 drugs we measure
1,281 prescriptions, Q2 2025 – Q1 2026

Patient Information Guide for Asparaginase Erwinia Chrysanthemi Injection

What It’s Used For

Rylaze is used as part of combination chemotherapy for these conditions:

  • Acute lymphoblastic leukemia (ALL)
  • Lymphoblastic lymphoma (LBL)
  • Rylaze is for adults and children 1 month or older who developed hypersensitivity to E. coli-derived asparaginase.

How It Works

Rylaze is an enzyme that turns the amino acid asparagine into aspartic acid and ammonia. This lowers asparagine in the blood.

Some leukemia cells make very little asparagine themselves and depend on the blood supply. Without it, those cells die.

Drug Class

Drug Class

  • Asparagine-specific Enzyme
Detailed classifications and sources

The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.

Drug Class

Established Pharmacologic Class (EPC)
  • Asparagine-specific Enzyme

The main drug class the FDA gives it. It is the class named on the drug’s label.

How It Works

Mechanism of action (MoA)

None listed for Asparaginase Erwinia Chrysanthemi Injection in the FDA’s index.

What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.

What It Does in the Body

Physiologic effect (PE)

None listed for Asparaginase Erwinia Chrysanthemi Injection in the FDA’s index.

From our Patient Information GuideRylaze is an enzyme that turns the amino acid asparagine into aspartic acid and ammonia. This lowers asparagine in the blood. Some leukemia cells make very little asparagine themselves and depend on the blood supply. Read How Asparaginase Erwinia Chrysanthemi Injection Works

A change it makes in how the body works.

Chemical Family

Chemical structure (CS)
  • Asparaginase

The chemical family it belongs to, by its structure.

Drug Family

WHO ATC classification
  • Other antineoplastic agents

How the World Health Organization groups it: by the part of the body it acts on and what it treats.

The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.

Dosage

Rylaze is injected into a muscle by a health care professional. It replaces a long-acting asparaginase product, using either an every-48-hours schedule or a Monday/Wednesday/Friday schedule.

  • Doses are based on body size, and large doses may be split among several injection sites.
  • You get premedication 30 to 60 minutes before to lower allergic reaction risk.
  • Blood tests, including liver tests and blood sugar, are checked regularly.

Your care team handles scheduling, so follow their directions.

Typical Doses

Your prescriber chooses your dose, so take it exactly as prescribed.

ALL or LBL, replacing a long-acting asparaginase, rylaze every 48 hours

Usual dose 25 mg/m2 injected into a muscle every 48 hours
  • 25 mg/m2 intramuscularly every 48 hours

ALL stands for acute lymphoblastic leukemia.

LBL stands for lymphoblastic lymphoma.

ALL or LBL, replacing a long-acting asparaginase, rylaze on a Monday/Wednesday/Friday schedule

Usual dose 25 mg/m2 into a muscle on Monday and Wednesday mornings, 50 mg/m2 on Friday afternoon
  • 25 mg/m2 intramuscularly on Monday morning and Wednesday morning, and 50 mg/m2 intramuscularly on Friday afternoon
  • Give the Friday afternoon dose 53 to 58 hours after the Wednesday morning dose

ALL stands for acute lymphoblastic leukemia.

LBL stands for lymphoblastic lymphoma.

Replacing one dose of calaspargase pegol products, 25 mg/m2 every 48 hours

11 doses of Rylaze

Replacing one dose of pegaspargase products, 25 mg/m2 every 48 hours

7 doses of Rylaze

Replacing one dose of calaspargase pegol products, Monday/Wednesday/Friday 25/25/50 mg/m2

9 doses of Rylaze

Replacing one dose of pegaspargase products, Monday/Wednesday/Friday 25/25/50 mg/m2

6 doses of Rylaze

See the Full Dosing Instructions on DailyMed →

Side Effects

Common side effects seen with Rylaze plus chemotherapy include:

Common side effects

  • Abnormal liver blood tests
  • Nausea
  • Muscle and joint pain
  • Infection
  • Tiredness
  • Headache
  • Fever with low white blood cell count (febrile neutropenia)
  • Bleeding or bruising
  • Mouth sores, belly pain, decreased appetite, diarrhea, high blood sugar and low potassium

When to get medical help

  • Get help right away for signs of a serious allergic reaction, such as swelling of the lips, face or eyes, hives, trouble breathing, wheezing, or a drop in blood pressure.
  • Call your care team for symptoms of pancreatitis (inflammation of the pancreas), such as severe stomach pain, nausea or vomiting.
  • Seek help for signs of a blood clot, such as sudden severe headache, chest pain or shortness of breath.
  • Report serious or unusual bleeding.
  • Report signs of liver problems, including rapid weight gain, fluid buildup in the belly, painful liver enlargement, or yellowing of the skin or eyes.
  • Tell your team about any fever or signs of infection.

Warnings and Precautions

  • Allergic reactions: These can be severe, including anaphylaxis. Treatment is stopped permanently for serious reactions.
  • Pancreatitis: Can be fatal if untreated. Rylaze is held or stopped depending on severity.
  • Blood clots: Serious clots such as pulmonary embolism occurred in 1% of patients.
  • Bleeding: Reported in 25% of patients and severe in 2%.
  • Liver toxicity: Includes hepatic veno-occlusive disease. Liver tests are checked at least weekly during treatment cycles.

Before You Start

  • Not for people with a prior serious allergic reaction to Erwinia asparaginase.
  • Not for people with a history of serious pancreatitis, clots or bleeding on earlier asparaginase therapy.
  • Not for severe liver impairment.
  • Can harm an unborn baby. Pregnancy testing is recommended first.
  • Use effective non-hormonal birth control during treatment and for 3 months after the last dose.
  • Do not breastfeed during treatment and for 1 week after the last dose.
  • Not established in children younger than 1 month.
  • Not enough data in people 65 and older.

Half-Life and How Your Body Processes It

After an intramuscular injection, Rylaze reaches its peak level in a median of about 12 hours. Its apparent half-life is about 16 hours. It is expected to be broken down into small peptides. Black or African American patients had 29% lower clearance, which may raise drug exposure. The effects of kidney or liver impairment have not been studied.

Storage

Store RYLAZE vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.

Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Asparaginase Erwinia Chrysanthemi Injection: Pharmacist Answers to Common Questions

Quick, plain-English answers to the questions patients ask most about Asparaginase Erwinia Chrysanthemi Injection — the kind of thing our pharmacy team would talk through with you at the counter.

What is Rylaze used for?

Rylaze is used with other chemotherapy to treat acute lymphoblastic leukemia and lymphoblastic lymphoma. It is for people 1 month and older who became allergic to E. coli-derived asparaginase.

How is Rylaze given?

It is injected into a muscle by a health care professional. You will get medicines beforehand to help prevent allergic reactions. Your team decides the schedule.

What side effects should I expect?

Common ones include abnormal liver tests, nausea, muscle pain, infections, tiredness and headache. Bleeding or bruising can also happen. Tell your team about anything that worries you.

When should I get urgent help?

Get help right away for trouble breathing, swelling of the face or lips, hives or severe stomach pain. Also report clot symptoms, serious bleeding, or yellowing of the skin or eyes.

Can I use Rylaze during pregnancy or while breastfeeding?

Rylaze can harm an unborn baby, so pregnancy testing is recommended first. Use effective non-hormonal birth control during treatment and for 3 months after. Do not breastfeed during treatment and for 1 week after the last dose.

What happens if I miss a dose of Rylaze?

Because it is given by your care team, contact them quickly to arrange the missed dose. Do not try to make up doses yourself.

Is asparaginase erwinia chrysanthemi injection available over the counter?

No. Asparaginase erwinia chrysanthemi injection is a prescription medicine: every asparaginase erwinia chrysanthemi injection product listed with the FDA is prescription only, so it is not sold over the counter. Your prescriber decides whether it is appropriate for you, and your pharmacist dispenses it.

When was asparaginase erwinia chrysanthemi injection first available?

The earliest FDA record we hold for asparaginase erwinia chrysanthemi injection is from 2021: its first approval in Drugs@FDA or its earliest product listing in the NDC Directory, whichever is older. Many older medicines were in use before their first formal FDA approval, so this is the earliest date on record, not necessarily when asparaginase erwinia chrysanthemi injection was first used.

What is the brand name of asparaginase erwinia chrysanthemi injection?

Asparaginase erwinia chrysanthemi injection is the generic name. Its brand names are Erwinaze and Rylaze.

What is the generic name of Erwinaze?

The generic name of Erwinaze is asparaginase erwinia chrysanthemi injection. A generic name is the name of the active ingredient, the same whichever company makes the medicine; a brand name belongs to one company. Your prescription label may show either name.

What drug class is asparaginase erwinia chrysanthemi injection?

Asparaginase erwinia chrysanthemi injection belongs to the drug class Asparagine-specific Enzyme, its established pharmacologic class on the FDA label.

What strengths does asparaginase erwinia chrysanthemi injection come in?

Asparaginase erwinia chrysanthemi injection is listed in the FDA's National Drug Code Directory in these forms and strengths. Injection (into a muscle): 20 mg/mL. A listing does not mean every pharmacy stocks every strength.

Where can I read the asparaginase erwinia chrysanthemi injection prescribing information (package insert)?

The full FDA-approved prescribing information for asparaginase erwinia chrysanthemi injection, also called the package insert or drug label, is published on DailyMed, the National Library of Medicine's library of FDA labels. Each company's version has its own label; this page is built from Jazz Pharmaceuticals, Inc.'s, revised Jul 1, 2025, and links to it on DailyMed.

Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI

Ask Anything About Asparaginase Erwinia Chrysanthemi Injection

Skip the scrolling. Ask in your own words and get an answer from Asparaginase Erwinia Chrysanthemi Injection’s FDA label and our pharmacists’ own work.

Try:

Name another drug or a supplement in your question and we check both.

AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
  • Sources: Asparaginase Erwinia Chrysanthemi Injection’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
  • Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
  • Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
  • Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.

More About Asparaginase Erwinia Chrysanthemi Injection on HelloPharmacist

Still have a question? A licensed pharmacist answers for free, usually within a day.
Detailed Data & References for Asparaginase Erwinia Chrysanthemi Injection Forms and strengths, pricing, billing codes, manufacturers, safety reports and sourcing: the data behind the page. Most people can stop here. Each section below opens on a tap.

Asparaginase Erwinia Chrysanthemi Injection Forms and Strengths (How It Comes)

Asparaginase Erwinia Chrysanthemi Injection comes in 1 dose form, the injection. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Asparaginase Erwinia Chrysanthemi Injection inactive ingredients by manufacturer.

Injection

Into a muscle
Brands Rylaze
How this form is used
What it may be used for
  • Rylaze is used with other chemotherapy to treat acute lymphoblastic leukemia and lymphoblastic lymphoma in people 1 month or older who became allergic to E. coli-derived asparaginase.
Important instructions
  • Rylaze is given by injection into a muscle, with injection sites rotated.
  • Rylaze should not be injected into scarred, reddened, inflamed or swollen skin.
  • Rylaze is given after premedication to lower the risk of allergic reactions.
  • Rylaze is given where anaphylaxis can be treated right away.
Available strengths 1 strength
1 FDA-listed product record ⓘ

Asparaginase Erwinia Chrysanthemi Injection on the U.S. Market: Products, Makers and Brands

How Asparaginase Erwinia Chrysanthemi Injection appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

1 company lists 1 Asparaginase Erwinia Chrysanthemi Injection product record with the FDA, mostly as injection; the earliest marketing or approval year on record is 2021. The one brand name in the directory today is Rylaze; the rest are generics.

1
Dose forms ⓘ
1
Labelers (makers, repackagers, distributors)
2
Brand names ⓘ
1
FDA-listed product records ⓘ
2021
Earliest FDA record ⓘ

Also listed with the FDA, not a patient dose form: Unfinished injection (1) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.

How Widely Asparaginase Erwinia Chrysanthemi Injection Is Used (Medicaid Data)

How many Asparaginase Erwinia Chrysanthemi Injection prescriptions Medicaid paid for in Q2 2025 – Q1 2026, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.

1,281
Medicaid prescriptions filled (Q2 2025 – Q1 2026)
$11.3M paid by Medicaid, before rebates

How commonly is Asparaginase Erwinia Chrysanthemi Injection prescribed? Of the 1,682 medications we measure, Asparaginase Erwinia Chrysanthemi Injection ranks #1,296 by Medicaid prescriptions — more than 23% of them.

Where Asparaginase Erwinia Chrysanthemi Injection ranks among the drugs we measure · Q2 2025 – Q1 2026 · neighbors ±5

Source: Medicaid State Drug Utilization Data (CMS), all states. 1 of the 2 listed Asparaginase Erwinia Chrysanthemi Injection NDCs had Medicaid claims.

Compare Asparaginase Erwinia Chrysanthemi Injection Products

A representative set of FDA-listed product records for Asparaginase Erwinia Chrysanthemi Injection — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Strength Route Manufacturer / Labeler Category ⓘ Details
💊Injection
20 mg/mL Intramuscular Jazz Pharmaceuticals, Inc. BLA View NDC →

Showing 1 of 1 products — FDA National Drug Code Directory. See every product, package size and price: browse all 1 Asparaginase Erwinia Chrysanthemi Injection NDCs →

Asparaginase Erwinia Chrysanthemi Injection Recall History

A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.

The FDA’s enforcement reports list no Asparaginase Erwinia Chrysanthemi recalls since July 2021.

✅No Asparaginase Erwinia Chrysanthemi recalls on record since July 2021

Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.

Asparaginase Erwinia Chrysanthemi Injection Brand Names

Asparaginase Erwinia Chrysanthemi Injection has 2 brand names on record: Erwinaze and Rylaze. Rylaze is in the FDA’s product directory today; Erwinaze is not. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.

Erwinaze not listed today Rylaze

Who Makes Asparaginase Erwinia Chrysanthemi Injection: Manufacturers and Labelers

One company lists Asparaginase Erwinia Chrysanthemi Injection products with the FDA. By number of product records, the largest are Jazz Pharmaceuticals, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.

Jazz Pharmaceuticals, Inc. 1

Sources for This Asparaginase Erwinia Chrysanthemi Injection Page

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. Prescribing information dated Jul 1, 2025, the label version this page reads. A label changes when the FDA approves new uses, doses or warnings, so this is not the day the page itself last changed. Read the full label on DailyMed
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Asparaginase Erwinia Chrysanthemi Injection.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.

Where this information comes from

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 1 clinical label set within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source.

Clinical labels in scope
1
Finished products in the current FDA directory
1
Companies listing them (makers, repackagers, distributors)
1
FDA labeler codes behind them ⓘ
1
Linked representative label ⓘ
Jazz Pharmaceuticals, Inc.
Linked label effective
Jul 1, 2025
Composite sections available
19
Linked SPL Set ID
857e53aa-1098-4dad-b654-0276cdd43e03
Linked SPL Document ID
cca29ff5-d000-43da-b64a-c65816a8a9c4
Open the linked representative label on DailyMed ↗

How this page is built

HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Jazz Pharmaceuticals, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →